CDW three-lens brief
Evidence-based stock research on CDW. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Outperforming SPY by 12.1pp over 30 days. · Debt-to-equity of 236.9 — balance-sheet-heavy.
- Outperforming SPY by 12.1pp over 30 days.
- Analyst mean target $166.20 — 23% above current (10 analysts).
- Debt-to-equity of 236.9 — balance-sheet-heavy.
CDW closed at $135.32 (-0.84%) as of 2026-04-25. Market cap: $17.46B. P/E (trailing) 16.7. Positives: outperforming SPY by 12.1pp over 30 days.; analyst mean target $166.20 — 23% above current (10 analysts).. Concerns: debt-to-equity of 236.9 — balance-sheet-heavy.. Last quarter: Revenue $5.51B, net income $279.50M, free cash flow $920.35M.
Why three lenses on CDW, not one.
A single reasoning model has blind spots it doesn’t know about. We examine CDWacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/CDW" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath CDW brief"></iframe>